| Valley Springs Medical Clinic | |
|
221 Co Rd 816 Black MO 63625 | |
| (537) 269-1035 | |
| (573) 269-1037 |
| Full Name | Valley Springs Medical Clinic |
|---|---|
| Speciality | Clinic/center - Federally Qualified Health Center (fqhc) |
| Location | 221 Co Rd 816, Black, Missouri |
| Authorized Official Name and Position | Sherilyn Clark (CEO) |
| Authorized Official Contact | 5736632313 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Valley Springs Medical Clinic Po Box 157 Ellington MO 63638-0157 Ph: (537) 663-2313 | Valley Springs Medical Clinic 221 Co Rd 816 Black MO 63625 Ph: (537) 269-1035 |
| NPI Number | 1184719064 |
|---|---|
| Provider Enumeration Date | 10/04/2006 |
| Last Update Date | 07/22/2013 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184719064 | NPI | - | NPPES |
| 509059002 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
Most primary care physicians (PCPs) and kidney specialists favor collaborative care for a patient with progressive chronic kidney disease (CKD), but their preferences on how and when to collaborate differ, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). PCPs and kidney specialists need to partner more effectively to optimize care for patients with CKD.
Nektar Therapeutics today announced positive results from a Phase 2 clinical study evaluating single-agent NKTR-102 in patients with metastatic breast cancer during the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS). NKTR-102, a novel investigational topoisomerase I inhibitor-polymer conjugate, is Nektar's lead oncology candidate and is being evaluated in multiple cancer indications.
A new study published in the American Journal of Preventive Medicine has determined that poorer childhood cognition occurred, particularly in memory and learning, when pregnant women or their offspring consumed greater quantities of sugar.
A novel PET radiotracer developed at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital is able for the first time to reveal epigenetic activity - the process that determines whether or not genes are expressed - within the human brain.
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces today that it has entered into a research-based collaboration with Santaris Pharma A/S, a leading player in RNA-based therapeutics, to develop its proprietary Locked Nucleic Acid (LNA) technology in a range of rare diseases, thereby enabling Shire to build on its already strong competitive position for its Human Genetic Therapies (HGT) business.
› Verified 1 days ago